NCT04388527View on ClinicalTrials.gov

COVID-19 Convalescent Plasma for Mechanically Ventilated Population

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

January 25, 2021

Study Completion Date

January 30, 2021

Conditions
Covid-19
Interventions
BIOLOGICAL

COVID-19 Convalescent Plasma

Participants will receive 2 units of convalescent plasma collected from ABO-compatible donors who have recovered from COVID-19.

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04388527 - COVID-19 Convalescent Plasma for Mechanically Ventilated Population | Biotech Hunter | Biotech Hunter